Jump to content

Lotrifen

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Boghog (talk | contribs) at 10:34, 15 August 2018 (reduced size of graphic). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Lotrifen
Clinical data
Trade namesCanocenta, Privaprol
Other namesTrazisoquine; L-12717; DL-717-IT
Identifiers
  • 2-(4-chlorophenyl)-[1,2,4]triazolo[5,1-a]isoquinoline
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.060.340 Edit this at Wikidata
Chemical and physical data
FormulaC16H10ClN3
Molar mass279.727 g/mol g·mol−1
3D model (JSmol)
  • C1=CC=C2C(=C1)C=CN3C2=NC(=N3)C4=CC=C(C=C4)Cl
  • InChI=1S/C16H10ClN3/c17-13-7-5-12(6-8-13)15-18-16-14-4-2-1-3-11(14)9-10-20(16)19-15/h1-10H
  • Key:DGWUVKLBXCWNTA-UHFFFAOYSA-N

Lotrifen (INNTooltip International Nonproprietary Name), also known as trazisoquine and sold under the brand names Canocenta and Privaprol, is an abortifacient which is used in veterinary medicine.[1][2] It was described in 1978.[1]

References

  1. ^ a b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 743–. ISBN 978-1-4757-2085-3.
  2. ^ Negwer, Martin; Scharnow, Hans-Georg (4 October 2001). Organic-chemical drugs and their synonyms: (an international survey). Wiley-VCH. p. 1184. ISBN 978-3-527-30247-5. {{cite book}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)